New Delhi [India], March 01 (ANI): Prime Minister Narendra Modi on Monday took the first dose of Covaxin, India's homegrown coronavirus vaccine developed by biotechnology firm Bharat Biotech and Indian Council of Medical Research, addressing the hesitancy over the COVID-19 vaccine.
New Delhi [India], February 26 (ANI): Bharat Biotech International Limited on Friday confirmed that the company has signed an agreement with Brazil for the supply of 20 million doses of Covaxin vaccine.
Kolkata (West Bengal) [India], February 24 (ANI): AIIMS Delhi Director Dr Randeep Guleria on Wednesday termed the government's move to vaccinate people above 60 years and above 45 years with comorbidities "as a very good step" and the move to expand the vaccination ambit will also help in
New Delhi [India], February 1 (ANI): Two Indian vaccine manufacturers--Serum Institute of India (SII) and Bharat Biotech--welcomed the allocation of Rs 35,000 crore on Covid-19 vaccination in the Union Budget presented by Finance Minister Nirmala Sitharaman on Monday.
New Delhi [India], January 28 (ANI): India's drug regulatory body has received requests from both Pune based Serum Institute of India and Hyderabad-based Bharat Biotech to make necessary changes in the vaccine fact sheet to allow people using blood thinners to get inoculated against Covid-19
New Delhi [India], January 22 (ANI): In a remarkable finding, India's indigenous Covid-19 vaccine--COVAXIN developed by the Bharat Biotech and Indian Council of Medical Research (ICMR) has shown high safety and immunogenicity during the phase 1 clinical trial, according to the findings of th
Chennai (Tamil Nadu) [India], January 22 (ANI): Tamil Nadu Health Minister Dr C Vijayabaskar received Bharat Biotech's Covaxin shot in Chennai on Friday.
Bengaluru (Karnataka) [India], January 19 (ANI): After the Karnataka Association of Resident Doctors' objected to taking the Covaxin shot developed by Hyderabad-based Bharat Biotech and requested the government to use Covishield vaccine instead, Karnataka Health Minister Dr K Sudhakar on Tue
New Delhi [India] January 16 (ANI): As India started its vaccination drive against COVID-19 on Saturday, members of Resident Doctors' Association (RDA) at RML hospital here expressed doubts over Covaxin, saying there is "lack of complete trial".
New Delhi [India], January 16 (ANI): Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe
New Delhi [India], January 15 (ANI): As India awaits the vaccine roll-out anxiously, the Delhi government on Friday announced that the Serum Institute of India (SII)-manufactured Covishield vaccine will be administered at 75 Delhi government and private hospitals while Bharat Biotech's CO
New Delhi [India], January 14 (ANI): Congress leader Manish Tewari on Wednesday said that emergency use authorization to COVID-19 vaccine 'Covaxin' raises concerns on its efficacy as phase three trials have not been completed and its roll out can't be used as phase three trial. He said India